0000930413-21-000037.txt : 20210113
0000930413-21-000037.hdr.sgml : 20210113
20210113213750
ACCESSION NUMBER: 0000930413-21-000037
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210111
FILED AS OF DATE: 20210113
DATE AS OF CHANGE: 20210113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bench David
CENTRAL INDEX KEY: 0001797876
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-09974
FILM NUMBER: 21527364
MAIL ADDRESS:
STREET 1: ENZO BIOCHEM, INC.
STREET 2: 527 MADISON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ENZO BIOCHEM INC
CENTRAL INDEX KEY: 0000316253
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 132866202
STATE OF INCORPORATION: NY
FISCAL YEAR END: 0731
BUSINESS ADDRESS:
STREET 1: 60 EXECUTIVE BLVD
CITY: FARMINGDALE
STATE: NY
ZIP: 11735
BUSINESS PHONE: 5167555500
MAIL ADDRESS:
STREET 1: ENZO BIOCHEM INC
STREET 2: 60 EXECUTIVE BLVD
CITY: FARMINGDALE
STATE: NY
ZIP: 11735
4
1
ownership.xml
X0306
4
2021-01-11
0
0000316253
ENZO BIOCHEM INC
ENZ
0001797876
Bench David
C/O ENZO BIOCHEM, INC.
527 MADISON AVENUE
NEW YORK
NY
10022
0
1
0
0
CHIEF FINANCIAL OFFICER
Stock Option (to acquire Common Stock)
2.63
2021-01-11
4
A
0
55400
0
A
2022-01-11
2026-01-11
Common Stock
55400
110800
D
The Reporting Person was granted 55,400 stock options. The stock options have a three-year term and will vest in three equal installments, one on the first anniversary of the grant date, the second on the second anniversary of the grant date and the third on the third anniversary of the grant date.
Does not include 15,000 Performance Stock Units granted to the Reporting Person on February 24, 2020, which will vest, if at all, based on (i) the achievement of certain average revenue growth and average adjusted EBITDA growth goals on February 24, 2023 and (ii) the continued employment of the Reporting Person through February 24, 2023.
/s/ David Bench
2021-01-13